First Horizon Advisors’s Takeda Pharmaceutical TAK Stock Holding History

First Horizon Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$12.7K	Buy	821 +136	+20%	+$2.01K	﹤0.01%	1590
2025 Q1	$10.2K	Hold	685	–	–	﹤0.01%	1592
2024 Q4	$9.07K	Hold	685	–	–	﹤0.01%	1641
2024 Q3	$9.74K	Buy	685 +215	+46%	+$3.05K	﹤0.01%	1614
2024 Q2	$6.08K	Hold	470	–	–	﹤0.01%	1705
2024 Q1	$6.53K	Sell	470 -105	-18%	-$1.53K	﹤0.01%	1744
2023 Q4	$8.21K	Buy	575 +188	+49%	+$2.67K	﹤0.01%	1657
2023 Q3	$5.99K	Buy	387 +84	+28%	+$1.3K	﹤0.01%	1702
2023 Q2	$4.76K	Sell	303 -965	-76%	-$15.8K	﹤0.01%	1807
2023 Q1	$20.9K	Buy	1,268 +655	+107%	+$10.4K	﹤0.01%	1250
2022 Q4	$9.56K	Buy	613 +250	+69%	+$3.49K	﹤0.01%	1579
2022 Q3	$4K	Hold	363	–	–	﹤0.01%	1839
2022 Q2	$5K	Buy	363 +329	+968%	+$4.7K	﹤0.01%	1848
2022 Q1	$0	Sell	34 -441	-93%	-$6.47K	﹤0.01%	2257
2021 Q4	$6K	Hold	475	–	–	﹤0.01%	1713
2021 Q3	$7K	Sell	475 -607	-56%	-$10.2K	﹤0.01%	1668
2021 Q2	$18K	Buy	1,082 +581	+116%	+$9.89K	﹤0.01%	1154
2021 Q1	$9K	Buy	501 +50	+11%	+$900	﹤0.01%	1333
2020 Q4	$8K	Hold	451	–	–	﹤0.01%	1125
2020 Q3	$7K	Buy	+451	New	+$8.21K	﹤0.01%	1101
2019 Q2	–	Sell	-212	Closed	-$4K	–	1637
2019 Q1	$4K	Buy	+212	New	+$4.27K	﹤0.01%	1305

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

First Horizon Advisors's TAK Position: Q2 2025 in Review

First Horizon Advisors increased its Takeda Pharmaceutical (TAK) stake by 20% in Q2 2025, buying an estimated $2.01K and bringing the position to 821 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1590.

First Horizon Advisors first reported a position in TAK in Q1 2019 and has held it in 21 quarters since. The position peaked at $20.9K in Q1 2023. 316 funds tracked by Wall St. Rank hold TAK as of Q2 2025.

First Horizon Advisors held 821 shares of Takeda Pharmaceutical worth $12.7K as of Q2 2025.
First Horizon Advisors bought 136 Takeda Pharmaceutical shares in Q2 2025, an estimated $2.01K.
Takeda Pharmaceutical made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1590 holding.
First Horizon Advisors first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 21 quarters since.
First Horizon Advisors's Takeda Pharmaceutical position peaked at $20.9K in Q1 2023.
316 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.